Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
48, Kandivli Industrial Estate,, Kandivli (West),
Mumbai; Maharashtra; Map
Postal Code: 400067
Tel: 66474444/ 6210
Fax: 2868

Full name: Ipca Laboratories Ltd.


Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 1624737
IN-CIN: L24239MH1949PLC007837
ISIN: INE571A01012
Incorporation Date: 1949

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Other Fiscal Benefits, Others, Other Services, Liquids (Oral), Injectibles, Formulation Capsules/Tablets, Basic Drugs/Intermediates,


Company Description

Ipca Laboratories Limited (IPCA), incorporated in 19 October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited, operates as a Pharmaceutical company . IPCA manufactures, supplies and exports API's Atenolol (Antihypertensive), Chloroquine Phosphate (Antimalarial), Furosemide (Diuretic) and Pyrantel Salts (Anthelmintic). The company has its registered office located in Mumbai.


Basic Information

Total Employees:
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 631.00
Volume 6,248
Turnover 3,976,696
Index    S&P CNX 500
Market Bombay Stock Exchange
Ticker 524494
Market Cap Market Cap 79,631,638
52 Week High 788.80
52 Week Low 405.90
Price to Earnings (P/E) 82.32
Earnings per Share (EPS) 7.39
Dividend Yield 1.2 (March 31, 2012)
Bookvalue 21,839,200
Enterprise Value 77,451,833
Quote updated on October 25, 2016
Note: data in INR Thousands.


2014: Imports INR 621,144.86 Thousands
Import connections ('000)
2014: Exports INR 2,187,826.64 Thousands
Export connections ('000)

Key Executives

Chairman & Managing Director

Ownership Details

Indian Promoters

Key Stats

Select Items to chart them. 2017 Q1
Net sales revenue
Total operating revenue
Operating profit (EBIT)
Net Profit (Loss)
Total assets N/A
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Dion Global Solutions Limited, EMIS Company Database.


Competitors - India


EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest